1) Catasys is a healthcare company that uses AI and telehealth to engage with members who avoid care through their OnTrak program, driving lasting behavior change and lowering costs.
2) Their proprietary PRE platform uses machine learning to identify high-cost members with behavioral health conditions and comorbidities who are not seeking treatment.
3) Catasys sees significant growth opportunities in expanding their OnTrak program to more health plans and states based on their track record of 54% savings per member and nearly 5:1 ROI for health plans.
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
Â
Catasys Presentation March 2020
1. We are the experts in AI-powered
and telehealth-enabled healthcare
engagement that drives lasting
behavior transformation
ÂŽ
2. The nationwide leader in engagement
1 Closing price on 3/13/20 2 Revenue Full Year 2019 3 Net New Member Enrollment Full Year 2019
Serving members of major health plans in 28 states and Washington, D.C.
2
CATS
Publicly traded on
NASDAQ since 2017
$10.56
Stock Price1
137%
y/y Enrollment Increase3
131%
y/y Revenue Growth2
$33.7B
Total Addressable
Market
ÂŽ
3. Behavioral health conditions cause or exacerbate
other chronic diseases (diabetes, hypertension,
coronary artery disease, COPD, and congestive heart
failure) which means that our members cost health
plans 4.5 times more than those without BH issues.
3
Those with treated Behavioral
Health/SUD make up less than 14% of
insured members but account for
$6K
$5K
$4K
$3K
$2K
$1K
PerMemberPerMonthCost3
Hypertension Asthma Bipolar Chronic Pain Diabetes CAD COPD CHF
All Others Catasys Eligible
The market opportunity
1in5American adults are
impacted each year with behavioral
health issues1 (substance use
disorder, anxiety, depression).
of total U.S. healthcare
spending.2
1SAMSHA National Survey on Drug Use and Health, published August 2019
2 Milliman, April 2014, Economic Impact of Integrated Medical-Behavioral Healthcare
ÂŽÂŽ
3 Catasys medical claims data across all customers and lines of business
4. * No Treatment for SUD is defined as not receiving treatment at any location, such as a hospital (inpatient), rehabilitation
facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or
prison/jail.
PAST YEAR, 2018 NSDUH, 12+
The National Survey on Drug Use and Health
indicates the majority of Catasys eligible
members are not seeking treatment.
4
Behavioral healthcare avoidance is the
PROBLEM
5. Our members
consciously or
unconsciously
AVOID CARE.
We address the
memberâs medical,
social and behavioral
barriers to engage
them with the health
system they would
otherwise avoid.
1Source: Catasys total member ratings of OnTrak Program across all health plans
ENGAGEMENT is the game-changing
SOLUTION
We donât require
members to take the
first step. We engage
those others cannot
reach.
68
Netflix
62
Amazon
72
Apple
The Catasys OnTrak program has
a member Net Promoter Score of
5
Catasys âMember Obsessionâ
drives engagement and loyalty
of Catasys
members
had not received
behavioral health
services in the last
12 months.
ÂŽ
1
The Net Promoter Score is calculated as the difference between the percentage of
Promoters and Detractors. The NPS is not expressed as a percentage but as an
absolute number lying between -100 and +100.
NPS = % of promoters - % of detractors
12
Average Health Plan
6. ~ At 20% enrollment that would be
$6.7 billion in revenue opportunity
for Catasys
Significant Upside
Catasys health plan partners comprise the
majority of the U.S. market
Total Addressable Market (TAM)
Commercial
Fully Insured
$7.7B
Medicare
Advantage
$3.8B
Commercial
ASO
$12B
Managed
Medicaid
$10.2B
for Substance Use Disorder, Anxiety and Depression
ÂŽ
6
Catasys OnTrakTM
Total Addressable Market
7. 1. AI âenabled hyper targeting of high cost, care-avoidant members
2. Proprietary identification algorithms for behavioral health conditions including
substance use disorder, anxiety, depression & chronic disease conditions
3. Flexible program duration with one trusted Catasys Care Coach
for up to 52 weeks
4. Industry-leading member retention and graduation rates
due to âfingerprinted âinterventions
5. Local and virtual resource: local Community Care Coordinators, Care Coaches, Providers,
Member Engagement Specialists AND a behavioral health telehealth network.
6. Unrivaled financial outcomes, durable medical claims savings and ROI.
7. Catasys methodology for evaluation of OnTrak program outcomes validated
by Milliman1.
Key Differentiators:
7
ÂŽ
A 15-year playbook on how to drive
lasting behavior transformation
1Milliman, actuarial industry leader, has peer reviewed the matched pairs study methodology used by Catasys to evaluate the OnTrak program and has found it reasonable and appropriate for the
circumstances. Specific calculations and conclusions were not reviewed.
8. We integrate machine learning, cutting edge analytics, fingerprinted engagement, care
coaching, network and digital tools to improve clinical outcomes and lower the cost of care.
Cognitive
Segmentation,
Behavioral Drivers & Goals
Care
Coaches
Multiple
Communication
Modalities
Program Type &
Duration
Credentialed
Network
Machine Learning
and AI
Community Care
Coordinators
Member Engagement
Specialists
OnTrakTM
Program
ÂŽ
8
9. We PREDICT and identify individuals for whom
behavioral or medical intervention could help.
We RECOMMEND care pathways that harness the
intersection between what is effective, evidence-
based care and what individuals are willing to do.
We ENGAGE through sophisticated techniques and
tools that encourage mental and physical behavior
change, reduce costs and improve outcomes.
We can achieve this for any chronic
disease.
PREDICT
RECOMMEND
ENGAGE
PRETM
Catasys PRE⢠is a cutting edge analytics platform that identifies members
who have both diagnosed and undiagnosed behavioral health conditions
and comorbidities.
9
ÂŽ
10. 10
An advanced analytic engine evolved over 10 years to
apply machine intelligence to manage data at scale and
provide actionable insight at unmatched speed.
Designed and built using highly diverse claims, third
party data and clinical data from OnTrakTM Application.
Populated with data from the nationâs largest health
plans representing millions of covered lives and
billions of individual data points.
ÂŽ
PRETM
Technology Platform
The data foundation for our
integrated solution
11. Revenue per patient enrolled $8,500
Revenue per enrolled member at ~80% retention $6,500
Revenue per 10,000 enrolled members $65,000,000
We deliver industry-leading ROI by
focusing on those members who can
benefit the most
11
ÂŽ
1. Validated ROI Methodology1
Healthcare IT Industry
2. Assume millions of members
will take the first step
3. Low cost savings per member
1. No/low ROI
2. Engage hundreds of thousands of very high
cost members
3. Industry-leading cost savings per member
1Milliman, actuarial industry leader, has peer reviewed the matched pairs study methodology used by Catasys to evaluate the OnTrak program and has found it reasonable and appropriate for
the circumstances. Specific calculations and conclusions were not reviewed.
12. ⢠Prior to treatment with Catasys, these
patients cost an average of $30,000
each year in medical costs (emergency
room visits and inpatient stays).
⢠Catasys provides health plans ~54% in
savings per enrolled member.
⢠Nearly a 5-to-1 ROI1 for health plans,
incentivizing them to pay 100% of the
treatment costs.
(Investment)
(Return)
1Health Plan ROI calculation = Return/Investment
Return On Investment
X2
$30,000
$16,200 $32,400
$6,500
$35K
$30K
$25K
$20K
$15K
$10K
$5K
Average
OnTrak
Program
Cost
2 Year
Cost
Savings2
Post
Graduation
Average
Savings2
Prior
Average
Health Plan
Cost
12
ÂŽ
AverageMedicalCostPerYear
2 Analysis of Catasys medical claims data across all customers and lines of business
13. 1
Launch 45 â 90 Days
Day
90
Day
45
Day
1
⢠Signing of contract
⢠Days to launch:
⢠45 days to launch in a previously entered state
⢠90 days to launch into a new state
⢠Clinical integration with the health plan requires little effort from
the health plan after transfer of data
⢠Enrollment is an iterative process after entering into a new state
⢠Approximately 12-15 months after launch to achieve
steady state of 20% enrollment
Greater than
20% in Year 2
Rapid Enrollment Ramp
(Commercial example)
12 Months
from Launch
20%
13
ÂŽ
14. Catasys saw a significant increase in the
effective eligible member population in 2019
as a result of new states and expansion
within existing health plans.
# of Individuals
Note: Historically, we reported total outreach pool, but believe the effective outreach pool is a better predictor of future revenue growth
1 An effective outreach pool of 108,120 individuals equates to a total outreach pool of 156,000 eligible lives.
2020 Quarterly Projections 14
250,000
200,000
150,000
100,000
20,000
Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3 2020 Q4 2020
35,553
40,674
47,388
55,811
102,266
108,1201
145,000
181,000
200,000 200,000
Accelerated Growth: Significant Ramp
in Effective Outreach Pool of Individuals
ÂŽ
15. ⢠Multi-year track record of outperforming guidance
⢠Supported through rapid enrollment growth
⢠Solely represents existing enrollment launches with current
health plan partners and several program expansions with
existing customers. Excludes new contracts and subsequent
launches, initial launches of existing contracts, and new
expansions within existing contracts.
15
2020 Financial Guidance of $90 Million
in GAAP Revenues
ÂŽ
In 2020
$7.7M
$100
$80
$60
$40
$20
2017 2018 2019 2020
$15.2M
$35.1M
$90M
Accelerating Revenue Growth
CatasysRevenue($M)
16. 16
Proven Leadership
CURT MEDEIROS
President & Chief Operating Officer
⢠20+ years experience in designing and executing growth strategies, establishing partnerships that
improve the healthcare system for all stakeholders
⢠Expertise in big data analytics to drive better outcomes and lower the cost of care
⢠Served nearly 10 years at UnitedHealth Group, most recently serving as President of OPTUM Analytics
⢠Joined Catasys in 2019, heading Catasys Operations, Sales and Marketing, and Digital Technology
TERREN PEIZER
Founder, Chairman & Chief Executive Officer
⢠Founder of several health care and life science companies
⢠Extensive background in venture capital, investing, mergers and acquisitions, corporate finance
⢠Held senior executive positions with investment banking firms Goldman Sachs, First Boston and
Drexel Burnham Lambert
⢠Chairman of Acuitas Group Holdings (personal holding company with ~57% Ownership of CATS)
⢠Chairman of Crede Capital Group, LLC, an industry leading Micro-Cap investment company
⢠Founder and Chairman of NeurMedix, Inc.
ÂŽ
17. We invest in innovative technology
to:
⢠Heighten Catasys operational
efficiency
⢠Address expanded populations
⢠Enhance clinical value
⢠Deliver improved member
experience and health
⢠Partner with health plans on
validated outcomes and savings.
ÂŽ
18. Except for statements of historical fact, the matters discussed in this press release are forward-looking
and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of
1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and
uncertainties, many of which are beyond our control, which may cause actual results to differ materially
from stated expectations. These risk factors include, among others, changes in regulations or issuance of
new regulations or interpretations, limited operating history, our inability to execute our business plan,
increase our revenue and achieve profitability, lower than anticipated eligible members under our
contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal
research studies, difficulty enrolling new members and maintaining existing members in our programs,
the risk that the treatment programs might not be effective, difficulty in developing, exploiting and
protecting proprietary technologies, intense competition and substantial regulation in the health care
industry, business disruption and related risks resulting from the outbreak of the novel coronavirus 2019,
high customer concentration, dependence on key personnel and the ability to recruit, retain and develop
a large and diverse workforce, the risks associated with the adequacy of our existing cash resources and
our ability to continue as a going concern, our ability to raise additional capital when needed and our
liquidity. You are urged to consider statements that include the words âmay,â âwill,â âcould,â âshould,â
âbelieves,â âestimates,â âprojects,â âpotential,â âexpects,â âplan,â âanticipates,â âintends,â
âcontinues,â âforecast,â âdesigned,â âgoal,â or the negative of those words or other comparable words to
be uncertain and forward-looking. For a further list and description of the risks and uncertainties we
face, please refer to our most recent Securities and Exchange Commission filings which are available on
its website at http://www.sec.gov. Such forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by law.
*Closing price on March 13, 2020
230 day average
At a Glance
Ticker NASDAQ: CATS
Stock Price* $10.56
Common Shares
Outstanding
16.7 Million
Float 7.5 Million
Average Daily
Volume2 151,060
Market Cap* $176.6 Million
Warrants
(WAEP $6.08)
1,550,975
Analyst Coverage
Canaccord Genuity,
Dougherty & Co.,
ThinkEquity
18
Forward-Looking Statements
ÂŽ